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AgonistAgricultural productivity is dictated by water availability and consequently drought is the major source
of crop losses worldwide. The phytohormone abscisic acid (ABA) is elevated in response to water deficit
and modulates drought tolerance by reducing water consumption and inducing other drought-protective
responses. The recent identification of ABA receptors, elucidation of their structures and understanding of
the core ABA signaling network has created new opportunities for agrochemical development. An
unusually large gene family encodes ABA receptors and, until recently, it was unclear if selective or
pan-agonists would be necessary for modulating water use. The recent identification of the selective
agonist quinabactin has resolved this issue and defined Pyrabactin Resistance 1 (PYR1) and its close
relatives as key targets for water use control. This review provides an overview of the structure and
function of ABA receptors, progress in the development of synthetic agonists, and the use of orthogonal
receptors to enable agrochemical control in transgenic plants.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Drought is the major source of crop losses worldwide and major
improvements to agricultural productivity may be realized by
improving water use and drought tolerance.1 There are many
strategies for mitigating the effects of drought on yield, including
the development of drought tolerant crops through breeding or
transgenic approaches;2–4 here we focus on abscisic acid (ABA 1,
Fig. 1) receptor agonists, which afford direct control of plant
transpiration by targeting a highly conserved family of receptors
that control a negative regulatory response pathway (Fig. 1). ABA
controls plant water use primarily through modulating ion trans-
port in guard cells, pairs of specialized epidermal cells that form
a stomatal pore that opens and closes in response to environmental
signals (Fig. 1). The accumulation of new biomass through
photosynthesis depends on entry of atmospheric CO2 to inner leaf
mesophyll cells through stomata, but this comes at the cost of H2O
escape driven by the large difference in water vapor pressure
between the inner leaf and atmosphere. Plants therefore face an
intrinsic tradeoff between water conservation and growth, and
consequently perturbations that reduce water consumption typi-
cally come at the cost of reduced growth. Conversely, selection
for high yielding crop varieties has been associated with increased
stomatal conductance in some crops.5,6Although the water/growth tradeoff may appear to create an
insurmountable dilemma from the perspective of increasing yields
during drought, the effects of drought vary throughout a plant’s life
cycle. In maize, for example, drought during the early juvenile
growth phases or late growth phases is less detrimental to final
grain yield than during flowering, where drought can cause repro-
ductive failure.7 Monsanto’s recently introduced DroughtGardTM
trait achieves 6% yield increases under conditions of moderate
drought by overexpression of a Bacillus subtilis cold-stress induced
RNA chaperone protein.4 This trait reduces the water consumption
of juvenile plants during water deficit, which in turn increases soil
water content at flowering relative to non-GMO controls.4 The
molecular mechanism of the trait’s physiological action is unclear,
but it nonetheless illustrates the potential of ‘water banking’ to
improve yield during drought. Synthetic ABA agonists, such as
quinabactin (2) and pyrabactin (3),8,9 are attractive because
agonists can, in principle, enable an agrochemical strategy for
water banking in any crop of interest.
2. Molecular aspects of ABA perception and action
S-(+)-ABA is a chiral sesquiterpenoid, with a decorated cyclo-
hexenone ring appended to a dienoic acid sidechain. ABA is derived
from b-carotene and was discovered in the 1960s by activity
guided identification of plant growth regulators.10–12 In addition
to its role in guard cell physiology, ABA mediates other abiotic
stress responses (for example freezing tolerance) and plays a cen-
tral role in inducing seed dormancy, controlling root architecture,
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Figure 2. 3-D aligned structures of receptor-bound ABA receptor agonists. (A) ABA
(3QN1), (B) quinabactin (4LA7), (C) pyrabactin (3NMN), (D) R-()-ABA, (E) overlay
of ABA and quinabactin, and (F) overlay of ABA and pyrabactin. The PDB accessions
used for the structures are listed in parentheses.
2. Quinabactin 
A B C D 
3. Pyrabactin 
1.  S-(+)Abscisic acid 
Figure 1. (A) Structures of S-(+) abscisic acid (1), quinabactin (2) and pyrabactin (3). (B) The gate-latch-lock structural mechanism for ABA recognition and biochemical
activation. The receptor is depicted as a gray cartoon, ABA is depicted in a gray CPK model, and the PP2C is depicted as a pink surface. (C) Biochemical pathway downstream of
activation of ABA receptors. (D) The physiological response of guard cell closure in the presence of ABA or other receptor agonists.
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tied to water status and cellular osmotic pressure; reductions in
osmotic pressure lead to rapid transcriptional induction of ABA
biosynthetic enzymes, in particular nine-cis epoxycarotenoid
dioxygenases (NCEDs), which act at the first committed step in
ABA biosynthesis.12 ABA levels rise greater than 25-fold under mild
drought conditions due to de novo ABA biosynthesis and hydroly-
sis of inactive glucose-esters.12,13 Mutants deficient in NCEDs or
other biosynthetic enzymes lose leaf turgor (i.e., wilt) more rapidly
than wild type plants.12,14 Conversely, treatment of plants with
exogenous ABA or synthetic agonists causes guard cell closure,
reduces transpiration, and prolongs the time before wilting occurs
relative to untreated plants.8,9,13,15 ABA also induces the transcrip-
tion of genes encoding enzymes that increase cellular osmolytes
levels, and has other drought-protective effects.16
ABA responses are mediated by a negative regulatory signaling
module that involves soluble Pyrabactin Resistance 1/PYR1-Like/Reg-
ulatory Component of ABA Receptor (PYR/PYL/RCAR) ABA receptors,
clade A type 2C protein phosphatases (PP2Cs) and subfamily 3
Snf1-related kinases (SnRK2s; Fig. 1). The SnRK2s directly phos-
phorylate and control the activity of several downstream effectors
such as transcription factors, and anion channels that are required
for guard cell closure.17 The SnRK2s autoactivate by cis- and trans-
autophosphorylation, but their activity is suppressed by the PP2Cs,
which dephosphorylate and inactivate the kinases.18,19 When ABA
binds to soluble PYR/PYL/RCAR ABA receptors, the receptors bind
stably within PP2C active sites and inhibit PP2C activity, this in
turn enables accumulation of activated SnRK2 kinases, which
regulate downstream factors by direct phosphorylation.20–22
ABA receptors are members of the START/Bet v 1 superfamily,5
an ancient family characterized by an a-b-a2-b6-a topology that
forms a helix-grip fold in which 7 anti-parallel beta-sheets (and
intervening short loops and helices) enclose a long C-terminal helix
to form a central ligand binding pocket.23–25 The structures of sev-
eral ligand–receptor complexes have been elucidated by X-ray
crystallography and depict the conformation of receptor-bound
ABA as a half-chair with a pseudoaxial sidechain26–32 (Fig. 2).
ABA binding induces a conformational change that enables the
receptors to dock into and inhibit PP2C activity. The largest confor-
mational change occurs in a ‘gate’-loop that flanks the ligandbinding pocket, which adopts a closed conformation via direct
hydrophobic contacts to ABA.26,27,29,30,33 A second ‘latch’-loop also
changes conformation and encloses the bound ligand (Fig. 1). The
sidechain of an invariant serine in the –SGLPA– gate-loop points
in towards the ligand binding pocket in apo-receptor structures
but becomes solvent exposed after agonist binding/gate closure,
which enables the closed conformer to bind and competitively
inhibit PP2C enzymatic activity. The majority of ABA recognition
occurs inside the receptors and involves 25 highly conserved resi-
dues that make direct or water-mediated contacts to ABA. Addi-
tionally, a critical PP2C tryptophan located in a recognition loop,
which is, specific to ABA regulated PP2Cs, called the ‘lock’, inserts
into a small pore directly above ABA’s 40-carbon and makes a water
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Figure 3. Arabidopsis ABA receptor sub-families. The left panel shows a phylogeny of the Arabidopsis thaliana PYR/PYL/RCAR receptors and the right panel shows IC50 values
for receptor-mediated inhibition of HAB1 by ABA, pyrabactin and quinabactin. (adapted from Ref. 8). PYL13 has been omitted, but it is a member of the PYL5 subfamily.
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lized by both direct and water-mediated hydrogen bonds, in addi-
tion to multiple hydrophobic interactions. Notably, a conserved
lysine in the PYL protein family (K59 in PYR1) forms a direct hydro-
gen bond to the carboxylate of ABA. A water-mediated H-bond net-
work interacts with both carboxylate oxygen atoms of ABA to
produce hydrogen bonding to residues homologous to PYR1’s
Y120, S122, and E141, which are part of a hydrophilic region located
deep within the pocket.26 The gate-latch interface facilitates
hydrophobic interactions with the cyclohexanone ring and the
70-, 80- and 90-methyl constituents of ABA,26,30 forming a hydropho-
bic region of the top of the pocket.
The ABA receptor gene family is unusually large, for example,
there are 14 members in Arabidopsis thaliana, 15 members in
tomato, and 21 members in soybean.35,36 The receptors form three
phylogenetically distinct subfamilies that can be found in all flow-
ering plant genomes sequenced (Fig. 3).37–39 The biological roles of
the different subfamilies are still being established, but as we
describe below, activation of the PYR1-subfamily of dimeric recep-
tors is sufficient to elicit guard cell closure, reduce water consump-
tion and induce ABA-transcriptional responses in many species,
which demonstrates its centrality in plant water relations.8
In Arabidopsis, there are nine clade A PP2Cs.40 One of the nine
PP2Cs (ABA Hypersensitive Germination 1, AHG1) is recalcitrant to
PP2C mediated inhibition due to a naturally occurring mutation of
the Trp lock residue.41 Genetic evidence indicates redundant/
overlapping functions for the PP2Cs,42 but biochemical evidence
demonstrates differences in ABA sensitivity for different PP2C–
receptor complexes,41,43 and at least one receptor (PYL13/RCAR7)
selectively interacts with a subset of clade A PP2Cs.44 The values
measured in receptor-mediated PP2C inactivation assays are thus
influenced by the specific PP2C utilized, and direct biophysicalmea-
surements, such as isothermal titration calorimetry (ITC), are valu-
able for inferring intrinsic agonist–receptor binding affinities. ITC
measurements have shown low micromolar Kd values,21,33,43,45,46
and that the inclusion of PP2Cs in binding reactions lowers apparent
Kds by 10- to 25-fold,21,45 presumably by reducing Koff. For exam-
ple, PYL5 displays an apparent Kd of 1 lM for ABA binding, which is
lowered to 38 nM by the addition of HAB1 to binding reactions.45 In
vivo potency, receptor–agonist Kd, and PP2C–inhibitory activity
generally correlate and IC50 values can be used to rank compound
potency and selectivity relative to ABA.8 Typical IC50 values for
ABA-mediated PP2C inhibition range from 20 to 300 nM (Fig. 3)
when assayed using the PP2Cs ABA Insensitive 1 (ABI1), ABA
Insensitive 2 (ABI2) or Homolog of ABI1 (HAB1).8,20,21,45Members of the PYR1 subfamily (PYR1, PYL1–3) form homod-
imers in solution, while the members of the other subfamilies
are monomeric and display higher ABA affinity.26,27,33,31 The
PYR1 homodimerization interface overlaps substantially with the
PP2C binding interface of the ligand-bound complex, which neces-
sitates dimer dissociation prior to ligand-induced PP2C inhibi-
tion.33,47 ABA shifts dimeric PYR1 towards a monomeric state
in vitro, as measured using size exclusion chromatography47 and
analytical ultracentrifugation, the latter of which has shown that
ABA increases the homodimerization Kds of PYL2 and PYL3 3-
to 6-fold.46 The decreased ABA affinity of dimeric receptors has
been proposed to result from a thermodynamic penalty imposed
by dimer dissociation,47 however it is also likely that an additional
hydrogen bond to ABA in monomeric receptors, as observed with
PYL9,32 contributes to differences in sensitivity as well. PYL10
was initially described as a constitutively active receptor,31 how-
ever this erroneous conclusion was due to an in vitro artifact
caused by the spurious ability of BSA (utilized in PP2C assays) to
weakly activate PYL10.48 Additionally, backbone dynamics mea-
surements indicate that PYL10’s conformational entropy increases
upon ABA binding, which may function to stimulate receptor–PP2C
interactions.48
Thus extensive biochemical analyses of Arabidopsis receptors
show that the PYR1 subfamily encodes dimeric receptors of lower
intrinsic affinity and sensitivity to ABA, while the PYL5- and
PYL8-subfamilies (Fig. 3) are monomeric, higher affinity receptors,
a pattern conserved in tomato and rice receptor subfamilies as
well.36,49 It has been hypothesized that the different subfamilies
function in different regions of the ABA dose response curve, with
the PYR1-subfamily being activated by the high ABA levels pro-
duced during abiotic stress.47 Genetic studies, however, have
shown additive contributions of several Arabidopsis receptors for
the control of stomatal conductance, implying overlapping
functions within guard cells.50 The PYL8 subfamily may contribute
differentially to root responses to ABA, as Arabidopsis the roots of
plants harboring pyl8 mutations are less sensitive to ABA in multi-
ple assays.51,52 Given the extensive genetic redundancy observed
for ABA receptors, selective agonists will undoubtedly help probe
receptor function in vivo.
3. Synthetic ABA receptor agonists
The identification of ABA receptors and elucidation of their
structures has created new opportunities for discovering and
designing modulators of receptor function. Although ABA could,
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ited by its molecular complexity, photolability,53–55 moderate
chemical stability,20,21 and rapid catabolic inactivation56,57 by plant
cytochrome P450s in the CYP707A subfamily.57 Synthetic agonists
with improved properties are therefore of interest and multiple
synthetic agonists have been described and characterized, as
have numerous ABA analogs (see below). These compounds have
revealed functional differences between receptors and defined
the dimeric ABA receptors as targets that can be used to chemically
control transpiration.
The identification and characterization of the selective agonist
pyrabactin (3) played a critical role in the identification of ABA
receptors. Pyrabactin was identified as a molecule that
phenocopies ABA’s inhibitory effect on seed germination using a
phenotype-based screen of a small molecule diversity library.20,58
Molecular and physiological characterization demonstrated that
pyrabactin activates seed ABA responses without strongly activat-
ing vegetative tissue ABA responses.20 Genetic mechanism-of-
action studies established that PYR1 is required for pyrabactin’s
bioactivity, that pyrabactin and ABA both directly bind to PYR1,
and that the key biochemical function of ABA agonists is to pro-
mote the formation of a receptor/PP2C complex that inhibits
PP2C activity.20 This work converged with the identification of
RCAR1 (PYL9), which was identified by characterization of PP2C
binding proteins and subsequent determination that RCARs bind
ABA to mediate PP2C inhibition.21 Additional studies identified
multiple members of the receptor family as binding partners
of ABI1 and HAB1.45,59 Collectively, these studies defined the
PYR/PYL/RCAR gene family as encoding ABA receptors. Numerous
groups had previously attempted to identify ABA receptors using
genetic approaches in Arabidopsis and in hindsight these attempts
failed because of the extensive genetic redundancy between the
14-members of the receptor gene family. PYR1 loss-of-function
mutants do not show pronounced defects in ABA responses, and
higher-order mutants are required to observe strong reductions
of ABA responses. Pyrabactin’s selective effects on seeds is a result
of both its preferential activation of PYR1 and the high level
expression of PYR1mRNA in seeds; features which allowed a single
loss of function mutation to reveal PYR1’s role in ABA signaling.
Thus, the selectivity of pyrabactin enabled it to bypass the func-
tional redundancy that had hampered discovery of ABA receptors
by forward genetic approaches.
Pyrabactin is a selective agonist that can activate PYR1, PYL1,
PYL5, and PYL10 (IC50 values of 660, 1200, 5200, and 1900 nM,
respectively, 2 to 60 that of ABA measured on the sameFigure 4. Variable amino acid residues within the ligand-binding pockets of Arabidopsis t
in PYR1.receptors). Since mutations in PYR1 block pyrabactin’s bioactivity,
it is likely that PYR1 is pyrabactin’s key cellular target. Why does
pyrabactin not activate all ABA receptors, like ABA does? This has
been addressed with genetic and structural studies dissecting the
differential pyrabactin sensitivity of PYR1 and PYL2,60–62 which
pinpointed two residues, PYR1 I110 and to a lesser degree I62, as
determinants of pyrabactin selectivity. PYL2 possesses smaller
valine residues at its corresponding residues (V67 and V114). Swap-
ping these residues to create the mutants PYR1I62V,I110V and
PYL2V67I,V114I converts PYL2 into a pyrabactin responsive receptor
and removes responsiveness from PYR1.60–62 X-ray crystallo-
graphic and HSQC-binding studies unexpectedly revealed that pyr-
abactin can bind to, but not activate, PYL2 because it binds in an
unproductive orientation that prevents gate closure.60–63 This
property makes pyrabactin an antagonist of PYL2, however it is
too weak to measurably antagonize ABA action in vivo.60,64 Thus,
PYR1 and PYL2 contain subtle sequence differences in ligand con-
tacting residues (Fig. 4) that can be exploited to tune agonist
selectivity.
Several analogs of pyrabactin (Fig. 5) have been characterized
and provide insight into structure–activity relationships.
Apyrabactin (4), a biologically inactive analog lacking the pyridyl
nitrogen, is unable to form a water-mediated hydrogen bond to
the highly conserved lysine (K59 in PYR1) that normally forms a
hydrogen bond to ABA’s carboxylate.60,62 Changing the positioning
of the nitrogen on the pyridyl ring (compound 5) or replacement of
the bromine atom on the naphthyl ring with hydrogen or a methyl
group (compounds 6 and 7) reduce activity. Non-polar alterations
to the naphthyl moiety are also detrimental, but to a lesser effect
(compounds 8 and 9),20 suggesting that the gate-latch-agonist
interface can tolerate subtle modifications in this region of the
pyrabactin scaffold.62 Replacement of pyrabactin’s pyridyl
methylamino substructure with a methionine-derivative (10), a
modification suggested from virtual screening experiments, yields
an equipotent compound in PYR1/PP2C binding assays.60 Bioisos-
teres of pyrabactin’s sulfonamide moiety have recently been
described: phosphonamide (11) and phosphonate substitutions of
the sulfonamide linker have yielded compounds with similar or
stronger effects than pyrabactin, however these analogs have not
been characterized biochemically.65 Pyrabactin’s napthyl ring can
be replaced by a naptholactam moiety (12), which can likely form
a hydrogen bond to the conserved gate-latch water, however the
activity of 12 is reduced in comparison to pyrabactin. Other
naptholactams that replace the pyridyl ring with a tetrahydrofu-
ranyl moiety (13) or an ethyl ester (14) display modest in vitrohaliana PYR/PYL/RCAR receptors. Shown at right are a representation of the residues
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Figure 5. Structures of pyrabactin and quinabactin analogs.
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described in the patent literature as compounds for controlling abi-
otic stress tolerance,66 however pyrabactin’s limited activity in
vegetative ABA responses will likely need to be circumvented in
order to develop agriculturally useful agents from this scaffold.
Nonetheless, pyrabactin has proven a valuable probe molecule
for both genetic and functional dissection of receptor function.
Given pyrabactin’s limitations, Okamoto et al. conducted small
molecule screens for compounds capable of activating multiple
receptors (PYR1–PYL4) using heterologous yeast two hybrid repor-
ter strains, which report agonist activity by the ligand-induced
physical interaction between receptors and PP2C.8,20,61 This
screening effort identified quinabactin (2), a dihydroquinolinone
sulfonamide that, like pyrabactin, contains two aromatic rings sep-
arated by a sulfonamide-containing linker. Remarkably, quin-
abactin (also named AM1) was independently isolated in a
screen for small molecules that induce PYR1-HAB1 binding using
a direct biophysical assay.9 Quinabactin possesses activity on
PYR1, PYL1, PYL2, PYL3 and PYL5 in phosphatase inhibition assays,
although its IC50 values for PYL3 and PYL5 are >10-fold higher than
ABA’s.8,9 Quinabactin also preferentially activates tomato dimeric
subfamily receptors.36
The biological effects of quinabactin are highly similar to those
of ABA, despite its inability to activate the full complement of ABA
receptors. Quinabactin inhibits Arabidopsis seed germination and
induces a genome-wide ABA-like transcriptional response in
seedlings.8,9 Quinabactin also induces guard cell closure and
reduces transpiration in multiple species and, like ABA, increases
survival after extended water deficit in Arabidopsis.8 Collectively,
these observations demonstrate that a pan-agonist is not necessary
for controlling guard cell and other vegetative ABA responses.
Although quinabactin most strongly activates the dimeric sub-
family of receptors, it also weakly activates PYL5. Mutational anal-
yses using a pyr1/pyl1/pyl2/pyl4 quadruple mutant genotype have
shown that PYL5 does not make a substantial contribution to quin-
abactin action. The pyr1/pyl1/pyl2/pyl4 quadruple mutant is ABA
hyposensitive in many assays, but still retains some ABA sensitivity
due to redundancy between receptors. For example, ABA-inducedtranscription of marker genes is reduced by only 80% in the
quadruple mutant strain. Subsequent genetic removal of PYL5
and PYL8 strongly enhances the ABA insensitivity of the quadruple
mutant, indicating that the residual ABA-response in the quadruple
is mediated by other PYL receptors.8,50 Unlike ABA however, quin-
abactin does not induce a residual transcriptional response in the
quadruple mutant, which is also highly insensitive to quinabactin’s
inhibition of seed germination.8 Collectively, these data show that
the dimeric receptors are targets that can be used to chemically
control transpiration, however the relative importance of specific
subfamily members is unclear. Quinabactin and pyrabactin differ
in that pyrabactin is unable to activate PYL2. This could imply that
PYL2 activation or co-activation is important for quinabactin’s
unique bioactivity. The development of agonists with greater selec-
tivity will help resolve this point. Additionally, the development of
agonists selective for the other subfamilies will help establish if the
other receptor subfamilies can be used to control transpiration.
Shortening quinabactin’s N-alkyl chain from N-propyl to N-
methyl (15) substantially reduces in vitro activity9, which can be
rationalized by reduced hydrophobic interactions with the 30-tun-
nel, a small hydrophobic pore directly above ABA’s 30-carbon that
forms after gate closure (Fig. 6A).64 The importance of this region
for modulating agonist interactions is supported by the improved
activity of ABA analogs (Fig. 7) that expand into this pocket. For
example, a series of 30-alkylsulfanyl ABA analogs (16 & 17) were
synthesized to probe this region.64 The analog AS2 (ethylsulfanyl-
ABA, 16) possesses increased agonist activity both in vitro and
in vivo and shows increased selectivity for the dimeric subfamily
receptors relative to ABA. AS2, like quinabactin, activates vegeta-
tive ABA responses, which provides independent support for the
conclusion that activating the dimeric receptors is sufficient to
reduce water use.64 The analog AS6 (hexylsulfanyl-ABA, 17), which
has a sufficiently long carbon chain to protrude through the 30-tun-
nel, blocks PYR1–PP2C interactions and antagonizes endogenous
ABA responses in multiple species.64
Manipulating hydrophobic interactions within the vicinity of
the 30-tunnel and gate may provide a general strategy for improv-
ing dimeric receptor agonist activity, as hydrophobic expansion
into the 30-tunnel improves activity of other ABA analogs. For
example, bicyclic tetralone ABAs (18), which incorporate ABA’s
30, 40 and 70 carbons into a phenyl ring, have improved activity
in vitro and in vivo.67–69 Tetralone-ABA derivatives with 110-alkyl
ether chains (19) that are predicted to extend into the 30-tunnel
gain favorable activity with short alkyl chains (n = 1), but suffi-
ciently long alkyl-chains (n = 4) yield antagonists.70 70-nor-ABA
(20), which replaces the 70-methyl with an H, which should reduce
hydrophobic interactions with the gate, has greatly reduced
in vitro and in vivo activity, indicating interactions in this region
are necessary with the ABA scaffold.71 Thus, modifications of
ligands in positions proximal to the 30 tunnel and gate can be used
to improve agonist activity or to engineer antagonists.64
Gate closure creates a second pore above ABA’s 40-carbonyl that
enables a water mediated contact between ABA’s ketone oxygen
and the PP2C Trp lock. Quinabactin’s quinolinone carbonyl oxygen,
which can be superimposed on ABA’s cyclohexenone oxygen when
comparing receptor–ligand complexes (Fig. 2F), participates in a
water mediated contact to the Trp lock.8,9 Quinabactin’s ability to
H-bond to the Trp lock likely underlies its improved activity rela-
tive to pyrabactin, as pyrabactin does not possess a hydrogen bond
acceptor positioned to interact with the Trp lock. Consistent with
the general importance of this interaction, 40-deoxo-ABA (21) dis-
plays greatly reduced bioactivity.72
Quinabactin’s 4-methylbenzyl methyl substituent occupies a
small cleft, which is normally occupied by ABA’s C6-methyl
(Fig. 6B). An analog of quinabactin that replaces the 4-methyl sub-
stituent with a hydrogen atom (22) has greatly reduced activity
Figure 6. The 30-tunnel (A) and C6-cleft (B) are variable regions of the receptors’ ligand-binding pockets. Amino acids that are variable between receptors are labeled with an
asterisk. V163 and F159, which are also part of the C6-cleft, have been omitted for clarity. Made from PDB 3QN1.
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the cleft are critical for activity. Consistent with this hypothesis,
the ABA analog 6-nor-ABA (23), which converts ABA’s C6 methyl
to an H, also shows greatly reduced activity.71 These studies
demonstrate the importance of agonist interactions with the
C6-cleft for activity. In addition, three of the 6 residues that form
the C6-cleft are variable between receptors (Figs. 4 and 6B), sug-
gesting that the C6-cleft might be exploited for tuning agonist
selectivity.
Pyrabactin and quinabactin are both constructed from two aro-
matic ring systems connected by a short sulfonamide linker and
both compounds adopt a similar U-shaped conformation (Fig. 2)
in the ligand binding pocket, positioning their hydrophobic rings
adjacent to the hydrophobic gate (30-and 40-tunnels) and C6-cleft,
which normally contact ABA’s hydrophobic cyclohexenone head
group and its C6-methyl, respectively. The sulfonamide linkage in
both molecules is positioned towards the bottom of the ligand
binding pocket and interacts with residues that would normallycontact ABA’s carboxylate and ring hydroxyl. In both agonists, their
sulfonamide NH forms a direct hydrogen bond to E94 (E98 in PYL2),
which normally participates in water-mediated H-bonds to ABA’s
carboxylate and ring hydroxyl groups. The pyr1–6 allele, which
encodes E94K, disrupts this residue and possesses strong pyrabac-
tin insensitivity in vivo, consistent with the critical importance of
this interaction to agonist activity.20 Across published ABA struc-
tures, ABA binding is stabilized by 4 water molecules that form
an H-bond network; quinabactin binding displaces 3 of these
waters, which may contribute favorably to the thermodynamics
of quinabactin binding.
4. Stereoselectivity, ABA affinity and ABA metabolism
S-(+)-ABA is the naturally occurring ABA, however some ABA
receptors can accommodate the R-()-isomer (24) if its ring rotates
180;11,26,28 R-()-ABA therefore possesses varying degrees of
bioactivity.74 The 180 rotation of the cyclohexenone ring needed
for ()-ABA binding causes the 80- and 90-methyl substituents to
occupy the space normally occupied by ABA’s 70-methyl. Not all
receptors can accommodate ()-ABA due to sequence variation
in residues homologous to I62 and I110 in PYR1 (which also influ-
ence pyrabactin sensitivity, as described above).28 For example,
wild type Arabidopsis PYL9 does not efficiently bind ()-ABA, but
PYL5 does. The PYL9 mutants V66I and I112V make their ligand
binding pockets more PYL5-like and imbue partial R-()-ABA
responsiveness on the mutant receptors.28 In addition to stereose-
lectivity, ABA receptors also display differences in their intrinsic
ABA binding affinities due to variable ligand-binding pocket archi-
tectures. For example, sequence variation in residues lining the
C6-cleft (Fig. 6) orient ABA in the monomeric receptor PYL9 so that
an additional H-bond between ABA’s carboxylate and N169 can
form. This H-bond is not observed in dimeric receptor/ABA com-
plexes and contributes to PYL9’s higher intrinsic ABA affinity.32
These data further illustrate the impact of relatively subtle
sequence variation between receptors on agonist selectivity and
affinity.
Manipulation of endogenous ABA levels provides an alternate
path to controlling plant water relations. The concentration of free
ABA is determined by rates of biosynthesis and catabolism and per-
turbations of either can change ABA levels.12 ABA is catabolized pri-
marily by oxidation of its ring methyl groups and glucosylation of
its carboxylate. The CYP707A subfamily of cytochrome P450
enzymes catalyze the formation of 80- and 90-OH ABA, which
spontaneously cyclize to form phaseic acid (PA) and neo-phaseic
J. D. M. Helander et al. / Bioorg. Med. Chem. 24 (2016) 493–500 499acid (neoPA), respectively.12,75 PA can be subsequently reduced to
dihydroPA (DPA). The major ABA metabolites are unlikely to
activate ABA receptors in vivo as PA, neoPA, 70-OH ABA, and ABA-
glucoside display IC50 values much lower than (+)-ABAwhen tested
with representative members of each receptor subfamily.68 Fluo-
rine substitutions on the 80-methyl group, in particular 80,80 difluo-
roabscicic acid and 80,80,80 trifluoroabscicic acid (25), yields
compounds with delayed metabolism in vivo and increased bioac-
tivity.76 Similarly, alkynyl derivatives at the 80 (26) and 90 position
have yielded CYP707A suicide inhibitors that are of interest because
they have more persistent biological effects than ABA.77 Both 80- and
90-acetylene ABA analogs display agonist activity comparable to that
of ABA in in vitro PP2C assays with multiple receptors, but a bulkier
80-cyclopropyl analog (27) shows reduced activity78 consistent with
the limited space available adjacent to the 80/90 methyls.
5. Engineered agrochemical control of transpiration
ABA agonists hold potential as future agrochemicals for control-
ling plant water consumption and improving yield under drought
conditions. A parallel strategy to gaining agrochemical control is
to engineer ABA receptors so that they can respond to an existing
agrochemical, a strategy based on orthogonal ligand/receptor sys-
tems, which have enabled selective chemical control of diverse tar-
gets.79,80 For example, several kinases have been engineered to
respond to kinase inhibitor analogs that are too bulky to inhibit
wild type kinases, but can inhibit mutant kinases with enlarged
ATP-binding pockets.80 The orthogonal/ligand receptor strategy
has been widely employed in chemical biology and used, for exam-
ple, to engineer receptors activated by ‘near drugs’, inactive drug
metabolites and other agonist/antagonist relatives.81–84
The orthogonal receptor/ligand design strategy commonly
involves the modification of existing ligands concomitant with
mutations to their receptors, however repurposing an existing
agrochemical is a different task. To identifying suitable ligands,
Park et al. used site-saturation mutagenesis to create a collection
of mutant PYR1 receptors that contain all possible 475 single
amino acid substitution mutations in the receptor’s 25 ligand-con-
tacting residues.85 This library of receptor variants was constructed
in combination with the PYR1-K59R mutation, which removes
intrinsic ABA responsiveness by disrupting a highly conserved
H-bond to ABA’s carboxylate.85,86 Park et al. screened a panel of
commonly used non-herbicidal agrochemical for agonists of any
of the 475 receptors using the yeast-two hybrid assay described
earlier. These screens were conducted at high concentrations
(100 lM) so that weakly interacting ligands could be identified
and subsequently optimized. Four weakly activating ligands were
identified and subsequent mutageneses and selections were
utilized to improve the sensitivity of each ligand–receptor pair
identified. This process worked most successfully with mandipro-
pamid (28), sold as RevusTM, which is used to control Phytophthora
infestans (late blight) in vegetable crops. Multiple rounds of
mutagenesis and functional selections yielded a hextuple mutant
receptor, PYR1MANDI, with nanomolar sensitivity to mandipropa-
mid. X-ray crystallographic data show that two key mutations that
replace bulky residues (F108A and F159L) are crucial for preventing
steric clashes between mandipropamid’s two O-propargyl sub-
stituents that would otherwise occur with the native receptor,
and that mandipropamid’s amide forms direct and water mediated
H-bonds to polar residues in the mutant’s binding pocket, func-
tioning analogous to the interactions of sulfonamides with wild
type receptors.85
Constitutive expression of PYR1MANDI in transgenic Arabidopsis
and tomato enables mandipropamid triggered activation of
multiple ABA responses, such as reduced transpiration andgenome-wide ABA-like transcriptional responses. Importantly,
overexpression of the mutant receptor, which does not possess
intrinsic ABA responsiveness, is not associated with growth defects
or substantial alterations of basal transcriptomes in the absence of
mandipropamid treatment. Mandipropamid applications are able
to improve Arabidopsis survival after water deficit with efficacy
similar to that of ABA, suggesting that mandipropamid could be
used as an agrochemical agent to control transpiration when used
in combination with PYR1MANDI.85 Additionally, the data demon-
strate that selectively activating a single receptor (when expressed
at high enough levels) is sufficient to elicit guard cell closure and
other important ABA responses. Thus, although ABA normally co-
activates multiple ABA receptors in vivo, co-activation is not a pre-
requisite for ABA action.
6. Looking forward
Growing demands on the freshwater needs of agriculture, due
to population growth and increasing weather extremes, are moti-
vating efforts to improve crop yields under conditions of drought.
Important improvements have already been achieved through
classical breeding and new transgenes, and these strategies will
likely continue to deliver improvements. Agrochemical modulators
of stress tolerance and water use have the advantage that they can,
in principle, be used with any genotype across multiple species.
ABA receptors are validated targets and it is anticipated that
agonists suitable for agriculture can be developed from existing
scaffolds. The isolation and characterization of quinabactin has
demonstrated the importance of dimeric ABA receptors as targets
for controlling transpiration, but our understanding of the underly-
ing biological functions of the multiple receptor subfamilies is still
incomplete. Structure–activity relationships of ABA-receptor ago-
nists will facilitate agonist and antagonist design efforts, which
will undoubtedly help probe receptor function and facilitate agro-
chemical development efforts. Ultimately, field studies will be
required to establish the efficacy of ABA agonists for improving
yield during drought.
The development of PYR1MANDI has demonstrated that an
existing agrochemical can be repurposed to control a defined trait
(transpiration via the ABA response pathway). The future of plant
biotechnology will undoubtedly involve greater use of engineered
proteins and pathways to specifically modulate defined traits.
Orthogonal control systems using agrochemical ligands offer the
advantage that the traits can remain silent in the absence of
chemical intervention.
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